Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
BMC Medicine|October 13, 2015
PCSK9 inhibition: the way forward in the treatment of dyslipidemiaRobert M Stoekenbroek, John J P Kastelein, Roeland HuijgenEuropean Heart Journal|March 7, 2012
Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variantsRoeland Huijgen, Iris Kindt, Joep C Defesche, et al.Circulation. Cardiovascular Genetics|May 4, 2012
Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FHRoeland Huijgen, Barbara A Hutten, Iris Kindt, et al.Journal of the American College of Cardiology|July 16, 2016
Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause MortalityJoost Besseling, G Kees Hovingh, Roeland Huijgen, et al.European Journal of Human Genetics : EJHG|October 25, 2007
Molecular screening for familial hypercholesterolaemia: consequences for life and disability insuranceSietske J M Homsma, Roeland Huijgen, Saskia Middeldorp, et al.Journal of the American College of Cardiology|December 3, 2016
Determining When to Add Nonstatin Therapy: A Quantitative ApproachJennifer G Robinson, Roeland Huijgen, Kausik Ray, et al.Atherosclerosis|January 9, 2016
Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemiaJoost Besseling, Roeland Huijgen, Seth S Martin, et al.Atherosclerosis|November 26, 2020
Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activationLaurens F Reeskamp, Tycho R Tromp, Roeland Huijgen, et al.Expert Review of Cardiovascular Therapy|April 12, 2008
Familial hypercholesterolemia: current treatment and advances in managementRoeland Huijgen, Maud N Vissers, Joep C Defesche, et al.Atherosclerosis|June 13, 2015
The impact of LDLR function on fibroblast growth factor 21 levelsJoost Besseling, Kwok Leung Ong, Roeland Huijgen, et al.Pageof 4